Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Beijing Tsinghua Chang Gung Hospital | OTHER |
| Beijing Tiantan Hospital | OTHER |
| Ruijin Hospital | OTHER |
| Nanfang Hospital, Southern Medical University |
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to construct hypertension specialized cohort using uniform standards and specifications. This study timely collected multi-dimensional clinical information through electronic medical records, mobile health, data integration, informatics and computer modern techniques, linking self-reported data and big data platforms from different sources to timely obtain the incidence and mortality data, and integrating hypertension cohort samples and the associated clinical records systematically, in order to build a 30-thousand hypertension specialized cohort with fine phenotypic data and blood/urine samples, thus far to provide support for the development of precise medicine research and related industries.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Hospital based hypertension cohort |
| ||
| Community based hypertension cohort |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Antihypertensive Agents | Drug | Single or combination therapy with five type of antihypertensive agents, such as Ca channel blockers, ACE inhibitors, ARBs, diuretics, or beta-blockers. |
| Measure | Description | Time Frame |
|---|---|---|
| Composite end point of major cardiovascular and cerebrovascular events | Composite end point of major cardiovascular and cerebrovascular events | From date of enrollment until date of first documented event or date of death from cardiovascular and cerebrovascular events, whichever came first, assessed up to 3 year |
| Measure | Description | Time Frame |
|---|---|---|
| New-onset of cardiovascular events | New-onset of cardiovascular events | From date of enrollment until date of first documented event or date of death from cardiovascular and cerebrovascular events, whichever came first, assessed up to 3 year |
| New-onset of stroke |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
primary care clinic, and community sample
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yue Qi, PhD | Contact | +861064456324 | qiyue_bjcn@163.com |
| Name | Affiliation | Role |
|---|---|---|
| Jing Liu, MD,PhD | Beijing Institute of Heart, Lung and Blood Vessel Diseases | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Beijing Anzhen Hospital | Recruiting | Beijing | China |
Not provided
| ID | Term |
|---|---|
| D006973 | Hypertension |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000959 | Antihypertensive Agents |
| D000082742 | Heart Disease Risk Factors |
| ID | Term |
|---|---|
| D002317 | Cardiovascular Agents |
| D045506 | Therapeutic Uses |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
Not provided
Not provided
| OTHER |
| Southwest Hospital, China | OTHER |
Not provided
Not provided
Not provided
Serum, plasma, blood cell, urine and DNA
| Cardiovascular risk factors | Other | Different level of cardiovascular risk factors associated with genetics, environments and lifestyles. |
|
New-onset of stroke |
| From date of enrollment until date of first documented event or date of death from cardiovascular and cerebrovascular events, whichever came first, assessed up to 3 year |
| Total death | Total death | From date of enrollment until date of death from all cause, assessed up to 3 year |
| Major bleeding | Major bleeding | From date of enrollment until date of first documented event or date of death from cardiovascular and cerebrovascular events, whichever came first, assessed up to 3 year |
| Atrial fibrillation | Atrial fibrillation | From date of enrollment until date of first documented event or date of death from cardiovascular and cerebrovascular events, whichever came first, assessed up to 3 year |
| Beijing Tiantan Hospital | Recruiting | Beijing | China |
|
| Beijing Tsinghua Chang Gung Hospital | Recruiting | Beijing | China |
|
| Southwest Hospital, China | Recruiting | Chongqing | China |
|
| Nanfang Hospital of Southern Medical University | Active, not recruiting | Guangzhou | China |
| Ruijin Hospital | Active, not recruiting | Shanghai | China |
| D012307 |
| Risk Factors |
| D012306 | Risk |
| D011336 | Probability |
| D013223 | Statistics as Topic |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D015984 | Causality |
| D015981 | Epidemiologic Factors |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D017531 | Health Care Evaluation Mechanisms |
| D011634 | Public Health |
| D004778 | Environment and Public Health |